Abstract
Background: There are few clinical data on technical limitations and radiocolloid kinetics related to sentinel lymph node (SLN) biopsy for breast cancer.
Methods: In 70 clinical node-negative patients, unfiltered99mTc sulfur-colloid was injected peritumorally and cutaneous hot spots were mapped with a gamma probe. SLN biopsy was performed followed by axillary lymph node dissection. Missed radioactive nodes (nodes not under hot spots) were removed from axillary lymph node dissection specimens and submitted separately.
Results: At least one hot spot was mapped in 69 patients (98%) and SLNs were retrieved in 62 (89%). No radiolabeled nodes were found in five (7%) and only nodes not under hot spots were retrieved in three patients (4%). Residual nodes not under hot spots were retrieved in 17 patients (24%) in whom at least one SLN specimen had been found. Diffuse radioactivity around the radiocolloid injection site impeded identification of all radiolabeled nodes during SLN biopsy, and was responsible for one of two false negatives (20 node-positive patients; false-negative rate 10%). Hot spot radioactivity, number of radiolabeled nodes, and nodal radioactivity did not change with time interval from radiocolloid injection to surgery (0.75–6.25 hours).
Conclusions: Although SLN localization rate is high, intraparenchymal injection may predispose to failure of radiocolloid migration, failure to identify SLNs because of high radiation background, and false-negative outcomes. Alternative routes of radiocolloid administration should be explored.
Similar content being viewed by others
REFERENCES
Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel node in breast cancer using a gamma probe. Surg Oncol 1993;2:335–340.
Krag DN, Ashikaga T, Harlow SP, et al. Development of sentinel node targeting technique in breast cancer patients. Breast J 1998;4:67–74.
Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391–401.
Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995;222:394–401.
Giuliano AE, Barth AM, Spivack B, Beitsch PD, Evans SW. Incidence and predictors of axillary metastasis in T1 carcinoma of the breast. J Am Coll Surg 1996;183:185–189.
Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in patients with breast cancer. JAMA 1996;276:1818–1822.
Pijpers R, Meijer S, Hoekstra OS, et al. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med 1997;38:366–368.
Veronesi U, Paganelli G, Galimberti V, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997;349:1864–1867.
Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet 1997;349:1668–1669.
Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345–2350.
Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998;227:645–653.
Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: A multicenter validation study. N Engl J Med 1998;339:941–946.
Gulec SA, Moffat FL, Carroll RG, et al. Sentinel lymph node localization in early breast cancer. J Nucl Med 1998;39:1388–1393.
Gulec SA, Moffat FL, Carroll RG. The expanding clinical role of intraoperative gamma probes. In: Freeman LM, ed. Nuclear medicine annual, 1997. Philadelphia: Lippincott-Raven, 1997:209–237.
Krag DN. Minimal access surgery for staging regional lymph nodes: The sentinel node concept. Curr Probl Surg 1998;35:951–1018.
Gulec SA, Moffat FL, Carroll RG, Krag DN. Gamma probe-guided sentinel node biopsy in breast cancer. Q J Nucl Med 1997;41:251–261.
Senofsky GM, Moffat FL, Davis K, et al. Total axillary lymphadenectomy in the management of breast cancer. Arch Surg 1991;126:1336–1342.
Moffat FL, Senofsky GM, Clark KC, Davis K, Robinson DS, Ketcham AS. Axillary node dissection for early breast cancer. Some is good, but all is better. J Surg Oncol 1992;51:8–13.
Temple WJ, Ketcham AS. Preservation of the intercostobrachial nerve during axillary dissection for breast cancer. Am J Surg 1985;150:585–588.
Aitken RJ, Gaze MN, Rodger A, Chetty U, Forrest APM. Arm morbidity within a trial of mastectomy and either nodal sample with selective radiotherapy or axillary clearance. Br J Surg 1989;76:568–571.
Jansen RFM, van Geel AN, de Groot HGW, Rottier AB, Olthuis GAA, van Putten WLJ. Immediate versus delayed shoulder exercises after axillary lymph node dissection. Am J Surg 1990;160:481–484.
Hladiuk M, Huchcroft S, Temple WJ, Schnurr BE. Arm function after axillary dissection for breast cancer: A pilot study to provide parameter estimates. J Surg Oncol 1992;50:47–52.
Maunsell E, Brisson J, Deschênes L. Arm problems and psychological distress after surgery for breast cancer. Can J Surg 1993;36:315–320.
Hack TF, Cohen L, Katz J, Robson LS, Goss P. Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 1998;17:143–149.
Valagussa P, Bonadonna G, Veronesi U. Patterns of relapse and survival following radical mastectomy. Cancer 1978;41:1170–1178.
Morrow M, Foster RS Jr. Staging of breast cancer: A new rationale for internal mammary node biopsy. Arch Surg 1981;116:748–751.
McMasters KM, Giuliano AE, Ross MI, et al. Sentinel lymph node biopsy for breast cancer—not yet the standard of care. N Engl J Med 1998;339:990–995.
Miner TJ, Shriver CD, Jaques DP, Minascalco-Theberge ME, Krag DN. Ultrasonographically guided injection improves localization of the radiolabeled sentinel lymph node in breast cancer. Ann Surg Oncol 1998;5:315–321.
Linehan DC, Hill ADK, Tran KN, et al. Sentinel lymph node biopsy in breast cancer: unfiltered radioisotope is superior to filtered. J Amer Coll Surg 1999;188:377–381.
Snider H, Dowlatshahi K, Fan M, Bridger WM, Rayudu G, Oleske D. Sentinel node biopsy in the staging of breast cancer. Am J Surg 1998;176:305–310.
Barnwell JM, Arredondo MA, Kollmorgen D, et al. Sentinel node biopsy in breast cancer. Ann Surg Oncol 1998;5:126–130.
Nwariaku FE, Euhus DM, Beitsch PD, et al. Sentinel lymph node biopsy, an alternative to elective axillary dissection for breast cancer. Am J Surg 1998;176:529–531.
Rubio IT, Korourian S, Cowan C, Krag DN, Colvert M, Klimberg VS. Sentinel lymph node biopsy for staging breast cancer. Am J Surg 1998;176:532–537.
Strand SE, Persson BRR. Quantitative lymphoscintigraphy: Basic concepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits. J Nucl Med 1979;20:1038–1046.
Foster RS Jr. The biologic and clinical significance of lymphatic metastases in breast cancer. Surg Oncol Clin N Am 1996;5:79–104.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moffat, F.L., Gulec, S.A., Sittler, S.Y. et al. Unfiltered Sulfur Colloid and Sentinel Node Biopsy for Breast Cancer: Technical and Kinetic Considerations. Ann Surg Oncol 6, 746–755 (1999). https://doi.org/10.1007/s10434-999-0746-4
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10434-999-0746-4